GLAXOSMITHKLINE BIOLOGICALS S.A.

Patent Owner

Follow Compare
1Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents Rank
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 93104
 
 
 
C07K PEPTIDES 1969
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1775
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1463
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9113
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 584
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 369
 
 
 
A47F SPECIAL FURNITURE, FITTINGS, OR ACCESSORIES FOR SHOPS, STOREHOUSES, BARS, RESTAURANTS, OR THE LIKE; PAYING COUNTERS224
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2136
 
 
 
B23P OTHER WORKING OF METAL; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS 140

Top Patents (by citation)

Patent # Title Filing Date Issue Date Intl Class Cited #
5,776,468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid AFeb 12, 96Jul 07, 98[A61K]62
6,558,670 Vaccine adjuvantsApr 29, 99May 06, 03[A61K]38
6,544,518 VaccinesOct 18, 00Apr 08, 03[A61K]32
5,770,208 Staphylococcus aureus B-linked hexosamine antigenSep 11, 96Jun 23, 98[A61K, C07K]29
6,146,632 VaccinesJul 02, 96Nov 14, 00[A61K]27
5,750,110 Vaccine composition containing adjuvantsFeb 17, 95May 12, 98[A61K]20
6,372,227 VaccinesApr 24, 00Apr 16, 02[A61K]13
D485365 VialSep 03, 02Jan 13, 04[2402]11
6,294,177 Staphylococcus aureus antigen-containing whole cell vaccineMay 10, 99Sep 25, 01[A61K]11
5,928,902 Hybrid protein between CS from plasmodium and HBsAgDec 04, 96Jul 27, 99[C12P, A61K, C07K]11

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2013/0095,135 PROCESS FOR REMOVING ADVENTITIOUS AGENTS DURING THE PRODUCTION OF A VIRUS IN CELL CULTUREJul 06, 11Apr 18, 13[C12N]
2013/0089,573 NOVEL PROCESSJun 08, 11Apr 11, 13[A61K]
2013/0084,309 PROCESS FOR THE PREPARATION OF O/W EMULSIONJun 08, 11Apr 04, 13[A61K]
2013/0079,395 NOVEL PROCESSJun 08, 11Mar 28, 13[A61K]
2013/0066,064 NOVEL PROCESSMay 18, 10Mar 14, 13[C07H, C09K, C08B]
2013/0039,943 NOVEL METHODApr 28, 11Feb 14, 13[C12N, A61P, A61K]
2012/0328,605 COMPOSITIONS AND USESMay 01, 12Dec 27, 12[A61P, A61K]
2012/0328,622 NOVEL COMPOUNDSJun 15, 12Dec 27, 12[C12N, A61P, G01N, A61K, C07K]
2012/0321,658 IMMUNOGENIC COMPOSITION COMPRISING S. PNEUMONIAE POLYSACCHARIDES CONJUGATED TO CARRIER PROTEINSAug 17, 10Dec 20, 12[A61P, A61K, C07K]
2012/0321,660 CONJUGATION PROCESS OF BACTERIAL POLYSACCHARIDES TO CARRIER PROTEINSMar 07, 11Dec 20, 12[A61P, A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,431,136 Immunogenic compositionJun 23, 06Apr 30, 13[A61K]
8,409,587 Immunogenic compositionOct 30, 03Apr 02, 13[A61K]
8,398,983 Immunogenic compositionJun 23, 06Mar 19, 13[A61K]
8,329,184 Process for manufacturing vaccinesJun 23, 06Dec 11, 12[C12P, A61K]
8,309,096 Fusion proteinJul 15, 09Nov 13, 12[A61K, C07K]
8,309,327 Method of producing an immunogenic compositionAug 31, 11Nov 13, 12[A61K]
8,232,255 Methods for vaccinating against malariaOct 22, 03Jul 31, 12[A61K]
8,221,770 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidisOct 21, 10Jul 17, 12[A61K]
8,217,159 BASB082 polynucleotidesJan 08, 10Jul 10, 12[C07H, A61K]
8,207,123 Tumour-specific animal proteinsAug 20, 10Jun 26, 12[A61K]

View all patents..

Top Inventors for This Owner

Inventor Name Address # of Patent/Pub
Poolman Jan
Rixensart, BE
63
Thonnard Joelle
Rixensart, BE
35
Denoel Philippe
Rixensart, BE
32
Garcon Nathalie
Rixensart, BE
25
Stephenne Jean
Rixensart, BE
24
Biemans Ralph Leon
Rixensart, BE
23
Feron Christiane
Rixensart, BE
18
Lobet Yves
Rixensart, BE
18